Although short-term dual antiplatelet therapy may eventually prove to benefit specific populations with very high stroke risk, the SPS3 trial definitively establishes that lacunar stroke alone is ...

Individuals with high PLMs had significantly higher Fazekas and ARWMC total scores than those with a lower PLM index.